These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 830926)

  • 61. Glycogen storage disease type 1: impact of medium-chain triglycerides on metabolic control and growth.
    Das AM; Lücke T; Meyer U; Hartmann H; Illsinger S
    Ann Nutr Metab; 2010; 56(3):225-32. PubMed ID: 20357432
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pathogenesis of malnutrition in cystic fibrosis, and its treatment.
    Pencharz PB; Durie PR
    Clin Nutr; 2000 Dec; 19(6):387-94. PubMed ID: 11104588
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Medium chain triglycerides in paediatric practice.
    Gracey M; Burke V; Anderson CM
    Arch Dis Child; 1970 Aug; 45(242):445-52. PubMed ID: 4918706
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Influence of lyophilized total pancreas on plasma lipids and on fat absorption in cystic fibrosis.
    Malmendier CL; Van Den Bergen CJ; Baran D
    Helv Paediatr Acta; 1977 Jul; 32(2):115-28. PubMed ID: 617969
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dietary problems of the dialysis patient.
    Panzetta G; Maschio G
    Blood Purif; 1985; 3(1-3):63-74. PubMed ID: 4096836
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nutritional aspects of chronic pancreatitis.
    Taubin HL; Spiro HM
    Am J Clin Nutr; 1973 Mar; 26(3):367-73. PubMed ID: 4571742
    [No Abstract]   [Full Text] [Related]  

  • 67. [Long-term use of medium chain triglycerides in cystic fibrosis (author's transl)].
    Widhalm K; Götz M
    Wien Klin Wochenschr; 1976 Sep; 88(17):557-61. PubMed ID: 997539
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Comparative double blind experience of a polyenzymatic preparation in chronic pancreatic insufficiency (author's transl)].
    Knill-Jones RP; Batten PJ; Williams R
    Acta Gastroenterol Belg; 1973 Sep; 36(9):489-504. PubMed ID: 4589486
    [No Abstract]   [Full Text] [Related]  

  • 69. Abnormal biliary lipid composition in cystic fibrosis. Effect of pancreatic enzymes.
    Roy CC; Weber AM; Morin CL; Combes JC; Nusslé D; Mégevand A; Lasalle R
    N Engl J Med; 1977 Dec; 297(24):1301-5. PubMed ID: 917086
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High dose pancreatic enzymes in cystic fibrosis.
    Robinson PJ; Sly PD
    Arch Dis Child; 1990 Mar; 65(3):311-2. PubMed ID: 2334211
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ketosis, weight loss, uric acid, and nitrogen balance in obese women fed single nutrients at low caloric levels.
    Bell JD; Margen S; Calloway DH
    Metabolism; 1969 Mar; 18(3):193-208. PubMed ID: 4887615
    [No Abstract]   [Full Text] [Related]  

  • 72. Assessment of medium-chain triglyceride feeding in infants with cystic fibrosis.
    Gracey M; Burke V; Anderson CM
    Arch Dis Child; 1969 Jun; 44(235):401-3. PubMed ID: 5785190
    [No Abstract]   [Full Text] [Related]  

  • 73. [Pancreatic enzyme substitution in patients with mucoviscidosis].
    Henker J
    Gastroenterol J; 1990; 49(4):151-5. PubMed ID: 2184824
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
    Zsíros J; Sólyom E
    Orv Hetil; 1988 May; 129(19):995-9. PubMed ID: 3290773
    [No Abstract]   [Full Text] [Related]  

  • 75. [Digestive and nutritional management of adults with cystic fibrosis].
    Marteau P; Munck A; Moreau J; Navarro J
    Rev Mal Respir; 2000 Aug; 17(3 Pt 2):785-97. PubMed ID: 11076388
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Digestion of fat and protein and its relation to the activity of faecal enzymes in mucoviscidosis infants under substitution therapy with pancreatic enzymes (author's transl)].
    Tolckmitt W; Lohmann A; Kutschera J
    Klin Padiatr; 1981 Sep; 193(5):365-9. PubMed ID: 6912903
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dietary intakes in adult patients with cystic fibrosis--do they achieve guidelines?
    White H; Morton AM; Peckham DG; Conway SP
    J Cyst Fibros; 2004 Mar; 3(1):1-7. PubMed ID: 15463880
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis.
    Bronstein MN; Sokol RJ; Abman SH; Chatfield BA; Hammond KB; Hambidge KM; Stall CD; Accurso FJ
    J Pediatr; 1992 Apr; 120(4 Pt 1):533-40. PubMed ID: 1552390
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Diagnosis and treatment of exocrine pancreatic insufficiency in mucoviscidosis].
    Shmerling DH
    Z Allgemeinmed; 1972 Aug; 48(24):1080-4. PubMed ID: 4649650
    [No Abstract]   [Full Text] [Related]  

  • 80. Assessment of weight loss, food intake, fat metabolism, malabsorption, and treatment of pancreatic insufficiency in pancreatic cancer.
    Perez MM; Newcomer AD; Moertel CG; Go VL; Dimagno EP
    Cancer; 1983 Jul; 52(2):346-52. PubMed ID: 6305473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.